Chesnara Plc: Fourth acquisition in two years
12 November 2026
Immunome, Inc. (NASDAQ: IMNM), a clinical-stage biotechnology company at the forefront of developing targeted cancer therapies, is catching the eyes of investors. With a compelling potential..
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS), a burgeoning player in the biotechnology industry, is capturing investor attention with its compelling growth metrics and favorable analyst ratings...
Delcath Systems, Inc. (NASDAQ: DCTH), a prominent name in the healthcare sector, particularly in the medical devices industry, is making waves with its innovative approach to..
Arbutus Biopharma Corporation (NASDAQ: ABUS) is a name that has been capturing investor attention, particularly with its promising 69.51% potential upside as highlighted by analyst price..
Investors seeking opportunities in the healthcare sector might find AMN Healthcare Services Inc (NYSE: AMN) an intriguing prospect. Despite recent operational challenges, the company is showing..
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is capturing investor attention with a promising upside potential of 65.17%, according to recent analyst ratings. Operating in the dynamic biotechnology..
SI-BONE, Inc. (NASDAQ: SIBN), a prominent player in the healthcare sector, is drawing significant attention from investors due to its innovative approach to addressing musculoskeletal disorders...
Investors with a keen eye on the medical devices industry should not overlook iRadimed Corporation (NASDAQ: IRMD). This healthcare sector player, headquartered in Winter Springs, Florida,..
Investors with an appetite for high-risk, high-reward opportunities might find Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) an intriguing prospect. This biotechnology company, valued at approximately $781.41 million,..
Pharvaris N.V. (NASDAQ: PHVS), a Switzerland-based biotechnology company, prominently stands out in the healthcare sector with its focus on developing innovative treatments for rare diseases. With..
Intellia Therapeutics, Inc. (NASDAQ: NTLA) stands at the forefront of the healthcare sector, particularly within the dynamic field of biotechnology. With a market capitalization of $1.23..
Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical stage biotechnology company, is making waves in the healthcare sector with its innovative therapies targeting inflammatory bowel diseases (IBD)..
Investors seeking exposure to the healthcare sector, particularly in the diagnostics and research industry, may find Fulgent Genetics, Inc. (NASDAQ: FLGT) an intriguing opportunity. With a..
CareDx, Inc. (NASDAQ: CDNA), a prominent player in the healthcare sector specializing in diagnostics and research, is drawing significant attention from investors with its substantial potential..
Trevi Therapeutics, Inc. (NASDAQ: TRVI) is capturing attention in the biotech sector with its significant potential upside, as highlighted by recent analyst ratings. Based in New..
HealthStream, Inc. (NASDAQ: HSTM) is capturing the attention of investors with its promising potential upside of 27.59%, according to the latest analyst consensus. As a key..
Vir Biotechnology, Inc. (NASDAQ: VIR) is a compelling case for investors with a keen eye on the biotechnology sector. Despite facing significant revenue challenges, the company..
In the ever-evolving world of biotechnology, LENZ Therapeutics, Inc. (NASDAQ: LENZ) stands out as a compelling story for investors. With a market capitalization of $973.01 million,..
Beta Bionics, Inc. (NASDAQ: BBNX), a promising player in the healthcare sector, is capturing investor attention with a significant potential upside of 78.93%. The company’s pioneering..
Investors interested in the biotechnology sector are increasingly turning their attention to uniQure N.V. (NASDAQ: QURE), a trailblazer in the development of gene therapies for rare..
